2022

1. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

   Lung Cancer, Vol. 166, pp. 228-241

2. Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

   eBioMedicine, Vol. 84

3. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

   Radiotherapy and Oncology, Vol. 168, pp. 75-82